scispace - formally typeset
L

Laura Maggi

Researcher at Sapienza University of Rome

Publications -  49
Citations -  5367

Laura Maggi is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Hippocampal formation & Microglia. The author has an hindex of 24, co-authored 45 publications receiving 4299 citations. Previous affiliations of Laura Maggi include International School for Advanced Studies & Pasteur Institute.

Papers
More filters
Journal ArticleDOI

Synaptic Pruning by Microglia Is Necessary for Normal Brain Development

TL;DR: It is shown that microglia actively engulf synaptic material and play a major role in synaptic pruning during postnatal development in mice and this work suggests that deficits in microglian function may contribute to synaptic abnormalities seen in some neurodevelopmental disorders.
Journal ArticleDOI

Dark microglia: A new phenotype predominantly associated with pathological states

TL;DR: Findings suggest that dark microglia, a new phenotype that is rarely present under steady state conditions, but becomes abundant during chronic stress, aging, fractalkine signaling deficiency, and Alzheimer's disease pathology, could play a significant role in the pathological remodeling of neuronal circuits, especially at synapses.
Journal ArticleDOI

CX(3)CR1 deficiency alters hippocampal-dependent plasticity phenomena blunting the effects of enriched environment.

TL;DR: It is found that CX3CR1 deficiency increases hippocampal plasticity and spatial memory, blunting the potentiating effects of EE, indicating that Cx3CL1/CX3 CR1-mediated signaling is crucial for a normal experience-dependent modulation of hippocampal functions.
Journal ArticleDOI

Fluoxetine effects on molecular, cellular and behavioral endophenotypes of depression are driven by the living environment

TL;DR: The hypothesis positing that SSRIs may not affect mood per se but, by enhancing neural plasticity, render the individual more susceptible to the influence of the environment is explored, suggesting that SSRI administration in a favorable environment promotes a reduction of symptoms, whereas in a stressful environment leads to a worse prognosis.